The company will be entitled to 180 days of marketing exclusivity on the products.Barr Pharmaceuticals (NYSE: BRL) announced Thursday that Barr Laboratories has received final approval from the U.S.
The company is entitled to 180 days of marketing exclusivity on the product.Barr Pharmaceuticals” (NYSE: BRL) subsidiary Barr Laboratories has received final approval from the U.S. Food and Drug ...
Allegra Tablet mg is used to treat seasonal allergic rhinitis, chronic idiopathic urticaria. However, the uses mentioned here are not exhaustive. Fexofenadine is an antihistamine which acts by ...
SAN FRANCISCO (MarketWatch) -- Mylan Laboratories Inc. said Wednesday its generic version of Aventis Pharmaceuticals' Allegra tablets have been granted tentative approval by the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback